Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sol-Gel Technologies ( (SLGL) ) has issued an update.
Sol-Gel Technologies Ltd. has announced its upcoming 2025 annual general meeting scheduled for November 11, 2025. Key agenda items include the appointment of Kesselman & Kesselman as independent auditors, re-election of board members, and re-appointment of Moshe Arkin as interim CEO. Shareholders will also review the company’s financial statements for the fiscal year ended December 31, 2024. The board recommends voting in favor of all proposals, which are crucial for the company’s governance and strategic direction.
Spark’s Take on SLGL Stock
According to Spark, TipRanks’ AI Analyst, SLGL is a Neutral.
Sol-Gel Technologies’ stock score reflects significant financial performance challenges due to negative profitability and cash flow issues. Positive technical indicators offer some short-term optimism, but the lack of valuation appeal and guidance from earnings calls creates uncertainty. Strategic financial improvements and clearer future guidance would be needed to enhance the stock’s attractiveness.
To see Spark’s full report on SLGL stock, click here.
More about Sol-Gel Technologies
Sol-Gel Technologies Ltd. is a company based in Israel, primarily engaged in the pharmaceutical industry, focusing on dermatological products. The company is known for its innovative solutions in topical drug delivery, targeting various skin conditions.
Average Trading Volume: 21,361
Technical Sentiment Signal: Hold
Current Market Cap: $77.44M
Find detailed analytics on SLGL stock on TipRanks’ Stock Analysis page.